Pfizer
Clinical development pipeline, platform architecture, and registered trial tracking for Pfizer vaccine candidates.
Development Phase Distribution
Platform Technologies
Target Pathogens & Indications
Vaccine Pipeline Candidates (23)
Detailed candidate profiles, clinical phases, target indications, and anticipated milestones.
ABRYSVO
Target: RSV
Platform: See FDA product page / label
PENBRAYA
Target: Meningococcal disease
Platform: See FDA product page / label
ACC-001
Target: Alzheimer's Disease
Platform: Biological (unspecified platform)
ACC-001+ QS21 (3mcg)
Target: Alzheimer Disease
Platform: Biological (unspecified platform)
Candidate 1: PF-07915234: VZV modRNA Powder for Suspension for Injection
Target: Varicella / Zoster
Platform: mRNA
IL-15 DNA (formulated with bupivacaine)
Target: HIV
Platform: DNA
MenABCWY (Pfizer)
Target: Meningococcal disease
Platform: Biological (unspecified platform)
PF-06755992
Target: Prostatic Neoplasms
Platform: Biological (unspecified platform)
Pfizer multivalent pneumococcal conjugate vaccine (unnamed)
Target: Pneumococcal disease
Platform: Biological (unspecified platform)
Pneumo 23
Target: Pneumococcal disease
Platform: Conjugate vaccine
Staphylococcus aureus 4-Antigen (SA4Ag) Vaccine
Target: Staphylococcal Vaccine
Platform: Biological (unspecified platform)
meningococcal B rLP2086 vaccine
Target: Meningococcal disease
Platform: Biological (unspecified platform)
PG4 in Buffer 1 with low dose PA-002
Target: Pneumococcal disease
Platform: Biological (unspecified platform)
C. difficile vaccine formulation 1.
Target: Clostridoides Difficile Associated Disease
Platform: Biological (unspecified platform)
Pfizer mRNA influenza vaccine candidates (#1-#6, unnamed)
Target: Influenza
Platform: mRNA
20vPnC
Target: Pneumococcal disease
Platform: Biological (unspecified platform)
C.difficile vaccine
Target: Clostridoides Difficile Associated Disease
Platform: Biological (unspecified platform)
PG4
Target: Pneumococcal disease
Platform: Biological (unspecified platform)
PG4 Multivalent Vaccine
Target: Pneumococcal disease
Platform: Conjugate vaccine
RSVpreF
Target: RSV
Platform: Biological (unspecified platform)
RSVpreF (Regimen A)
Target: RSV
Platform: Biological (unspecified platform)
RSVpreF Vaccine
Target: RSV
Platform: Biological (unspecified platform)
VLA15
Target: Lyme disease
Platform: Protein subunit (OspA)
Explore Other Vaccine Developers & Sponsors
Compare pipeline volume, phase progression, and modalities across global biopharmaceutical manufacturers.